Literature DB >> 10976534

Level of interleukin-8 expression by metastatic human melanoma cells directly correlates with constitutive NF-kappaB activity.

S Huang1, A DeGuzman, C D Bucana, I J Fidler.   

Abstract

The purpose of this study was to determine whether constitutive NF-kappaB activity regulates the expression level of interleukin-8 (IL-8) in metastatic human melanoma cells. Cultures of metastatic human A375 melanoma cells expressed higher levels of IL-8 mRNA and protein than nonmetastatic A375 human melanoma cells. No discernible differences in IL-8 half-life were found between metastatic and nonmetastatic cells, but cells that overexpressed IL-8 had a higher transcription rate and increased IL-8 promoter activity. Analysis of the IL-8 promoter using deletion mutants revealed that the region within -133 was essential for constitutive IL-8 promoter activity and that mutation of NF-kappaB binding sites eliminated the constitutive IL-8 promoter activity. The activation of constitutive IL-8 transcription directly correlated with the level of constitutive NF-kappaB activity. Transfection of melanoma cells with a dominant-negative mutant IkappaBalpha expression vector (pLXSN-IkappaBalphaM) significantly decreased the level of constitutive NF-kappaB activity and expression of IL-8, demonstrating that constitutive NF-kappaB/relA activities contribute to overexpression of IL-8 in highly metastatic human melanoma cells.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10976534     DOI: 10.1080/13684730050515868

Source DB:  PubMed          Journal:  Cytokines Cell Mol Ther        ISSN: 1368-4736


  18 in total

1.  Expression of interleukin-8 correlates with angiogenesis, tumorigenicity, and metastasis of human prostate cancer cells implanted orthotopically in nude mice.

Authors:  S J Kim; H Uehara; T Karashima; M Mccarty; N Shih; I J Fidler
Journal:  Neoplasia       Date:  2001 Jan-Feb       Impact factor: 5.715

2.  Tris (dibenzylideneacetone) dipalladium, a N-myristoyltransferase-1 inhibitor, is effective against melanoma growth in vitro and in vivo.

Authors:  Sulochana S Bhandarkar; Jacqueline Bromberg; Carol Carrillo; Ponniah Selvakumar; Rajendra K Sharma; Betsy N Perry; Baskaran Govindarajan; Levi Fried; Allie Sohn; Kalpana Reddy; Jack L Arbiser
Journal:  Clin Cancer Res       Date:  2008-09-15       Impact factor: 12.531

3.  Nuclear factor κB-dependent regulation of angiogenesis, and metastasis in an in vivo model of thyroid cancer is associated with secreted interleukin-8.

Authors:  Kevin T Bauerle; Rebecca E Schweppe; Gregory Lund; Gregory Kotnis; Gagan Deep; Rajesh Agarwal; Nikita Pozdeyev; William M Wood; Bryan R Haugen
Journal:  J Clin Endocrinol Metab       Date:  2014-04-23       Impact factor: 5.958

Review 4.  Nf-kappa B, chemokine gene transcription and tumour growth.

Authors:  Ann Richmond
Journal:  Nat Rev Immunol       Date:  2002-09       Impact factor: 53.106

5.  Expression profiling of Galectin-3-depleted melanoma cells reveals its major role in melanoma cell plasticity and vasculogenic mimicry.

Authors:  Alexandra A Mourad-Zeidan; Vladislava O Melnikova; Hua Wang; Avraham Raz; Menashe Bar-Eli
Journal:  Am J Pathol       Date:  2008-11-06       Impact factor: 4.307

6.  Importance of polymorphisms in NF-kappaB1 and NF-kappaBIalpha genes for melanoma risk, clinicopathological features and tumor progression in Swedish melanoma patients.

Authors:  Huajie Bu; Inger Rosdahl; Xiao-Feng Sun; Hong Zhang
Journal:  J Cancer Res Clin Oncol       Date:  2007-05-11       Impact factor: 4.553

7.  CCAAT displacement protein regulates nuclear factor-kappa beta-mediated chemokine transcription in melanoma cells.

Authors:  Yukiko Ueda; Yingjun Su; Ann Richmond
Journal:  Melanoma Res       Date:  2007-04       Impact factor: 3.599

8.  Chemotherapeutic drugs and human tumor cells cytokine network.

Authors:  Vera Levina; Yunyun Su; Brian Nolen; Xiaoning Liu; Yuri Gordin; Melissa Lee; Anna Lokshin; Elieser Gorelik
Journal:  Int J Cancer       Date:  2008-11-01       Impact factor: 7.396

9.  Nuclear factor-κB expression is predictive of overall survival in patients with cutaneous melanoma.

Authors:  Daniela Murtas; Franca Piras; Luigi Minerba; Jorge Ugalde; Michela Piga; Cristina Maxia; Maria Teresa Perra; Paola Sirigu
Journal:  Oncol Lett       Date:  2010-07-01       Impact factor: 2.967

10.  Overexpression of tissue inhibitors of metalloproteinase 2 up-regulates NF-kappaB activity in melanoma cells.

Authors:  Jun Sun; William G Stetler-Stevenson
Journal:  J Mol Signal       Date:  2009-07-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.